Eastern Europe’s Sole Pharma enters Philippine market
Sole Pharma headquarters in Latvia – Contributed photo
MANILA, Philippines — European pharmaceutical manufacturer Sole Pharma has debuted into the Philippine market, catering to rising demand for health-care products.
The Latvia-based company said that Filipinos were turning to “trusted” supplements for support as modern life presented increasing challenges, ranging from stress management to maintaining cognitive and physical health.
“Sole Pharma is committed to empowering people to live healthier, more energetic lives,” Sole Pharma Healthcare Business Unit Manager Elza Muizniece said in a statement on Wednesday.
“We believe that health and wellness should be accessible. We’re excited to be part of the Filipino’s journey towards a healthier future, one supplement at a time,” she said further.
According to the company, the local supplement industry is projected to grow at a rate of 9.32 percent from 2024 to 2029.
READ: Improved pharma regulatory standard to help boost its market
The company pitches what it describes as “science-backed, high-quality formulations.”
“Our commitment to responsible manufacturing and community support sets Sole Pharma apart, and we’re proud to uphold these values as we continue to grow,” Muizniece said.
The company currently carries six brands, including memory enhancer supplement Sole Max and stress management supplement Stressnol.
It also manufactures Focumax, an eye care supplement, along with Immunity Glucan, an immunity booster.
Likewise, the firm also produces Artroveron, a supplement for knee and joint support, and Hepastrong, for liver care.
It said that its products were now available at major drugstores, including Mercury Drug, Watson’s, Rose’s Pharmacy, Allgreen RX, and Evercare Pharmacy, as well as online via Lazada and Shopee.
